Retevmo (selpercatinib) for the Treatment of RET-Driven Cancers

Image 3-Retevmo
RetevmoTM (selpercatinib) is available as an oral capsule with dosage strengths of 40mg and 80mg. Credit: Eli Lilly and Company.